11585614910
Roche
DIG-High Prime DNA Labeling and Detection Starter Kit II
sufficient for 12 labeling reactions (10 ng to 3 μg per assay), sufficient for 24 blots (blots of 100 cm2)
Synonym(s):
DIG system, dna labeling
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
UNSPSC Code:
41105500
Recommended Products
usage
sufficient for 12 labeling reactions (10 ng to 3 μg per assay)
sufficient for 24 blots (blots of 100 cm2)
Quality Level
manufacturer/tradename
Roche
greener alternative product characteristics
Designing Safer Chemicals
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
greener alternative category
storage temp.
−20°C
General description
DIG-High Prime DNA Labeling and Detection Starter Kit II is a convenient kit for random-primed labeling of DNA templates with digoxigenin (DIG)-11- deoxyuridine triphosphate (dUTP), alkali-labile and chemiluminescent detection of the DIG-labeled hybrids. This kit was assembled with convenience in mind, offering ready-to-use CSPD supplied with a dripping device for easy application, ready-made blocking solution, and DIG Easy Hyb granules. The DIG-High Prime mixture includes stabilized Klenow enzyme, nucleotides, primers and reaction buffer, all in one convenient reagent.
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product is designed as a safer chemical. The DIG System was established as a sensitive and cost-effective alternative to radioactivity for the labeling and detection of nucleic acids. There are many available publications that prove the versatility of the DIG System, so use of radio-labeling is no longer the only option for labeling of DNA for hybridization.
Application
DIG-High Prime DNA Labeling and Detection Starter Kit II has been used in a variety of hybridization techniques:
- in Southern blots
- in northern blots
- in dot blots
- in colony and plaque hybridizations
- for all types of filter hybridization
- for single-copy gene detection in total genomic DNA, even from organisms with high complexity, for example, human, barley, and wheat
Packaging
1 kit containing 7 components.
Principle
The DIG High Prime DNA Labeling and Detection Starter Kit II uses digoxigenin (DIG), a steroid hapten, to label DNA probes for hybridization and subsequent chemiluminescence detection by enzyme immunoassay. The "random primed" DNA labeling method originally developed by Feinberg and Vogelstein is based on the hybridization of oligonucleotides of all possible sequences to the denatured DNA to be labeled. The input DNA serves solely as a template for the synthesis of labeled DNA, and is not degraded during the reaction, making it possible to label minimal amounts of DNA (10 ng) with this method.The complementary DNA strand is synthesized by Klenow polymerase using the 3′-OH termini of the random oligonucleotides as primers. Modified deoxyribonucleoside triphosphates, labeled with digoxigenin present in the reaction, are incorporated into the newly synthesized complementary DNA strand.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Kit Components Only
Product No.
Description
- DIG-High Prime 5x concentrated
- DIG-labeled Control DNA, pBR328 (linearized with Bam HI) 5 μg/ml
- DNA Dilution Buffer
- Anti-Digoxigenin-AP Conjugate antibody
- CSPD ready-to-use
- Blocking Solution 10x concentrated
- DIG Easy Hyb Granules
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 3
Flash Point(F)
does not flash
Flash Point(C)
does not flash
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Bushra Hafeez Kiani et al.
Malaria journal, 15(1), 252-252 (2016-05-05)
Malaria is causing more than half of a million deaths and 214 million clinical cases annually. Despite tremendous efforts for the control of malaria, the global morbidity and mortality have not been significantly changed in the last 50 years. Artemisinin, extracted
Rajiv R Mohan et al.
PloS one, 6(4), e18771-e18771 (2011-05-03)
Untargeted and uncontrolled gene delivery is a major cause of gene therapy failure. This study aimed to define efficient and safe tissue-selective targeted gene therapy approaches for delivering genes into keratocytes of the cornea in vivo using a normal or
Yu Du et al.
Tetrahedron, 67(35), 6568-6575 (2011-08-27)
The apoptolidins are 20/21-membered macrolides produced by Nocardiopsis sp. FU40. Several members of this family are potent and remarkably selective inducers of apoptosis in cancer cell lines, likely via a distinct mitochondria associated target. To investigate the biosynthesis of this
Emmanuel Ogwok et al.
Journal of virological methods, 169(2), 296-304 (2010-08-10)
Cassava brown streak disease (CBSD), caused by two distinct species, Cassava brown streak Uganda virus (CBSUV) and Cassava brown streak virus (CBSV), is a major constraint to cassava (Manihot esculenta Crantz) production in Africa. Absence of infectious clones of CBSUV
Erum Dilshad et al.
PloS one, 10(10), e0140266-e0140266 (2015-10-09)
The potent antimalarial drug artemisinin has a high cost, since its only viable source to date is Artemisia annua (0.01-0.8% DW). There is therefore an urgent need to design new strategies to increase its production or to find alternative sources.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service